1.
JAMA Netw Open
; 6(11): e2342741, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37948085
RESUMO
This case-control study assesses cerebrospinal fluid markers of neuroinflammation and blood-brain barrier disruption in individuals with postCOVID-19 condition who reported neuropsychiatric symptoms.